AEGiS-IRIN: Zimbabwe: A timeline of HIV/AIDS funding woes UN Integrated Regional Information NetworkImportant note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
Click here to return to UN Integrated Regional Information Network main menu
DonateNow




Zimbabwe: A timeline of HIV/AIDS funding woes

Integrated Regional Information Networks - August 12, 2009


JOHANNESBURG, 12 August 2009 (IRIN) - Zimbabwe and international donors have had a long but uneasy relationship in the fight against HIV/AIDS - especially when it came to the money. Despite having one of the world's highest HIV prevalence rates, Zimbabwean proposals to the Global Fund to Fight AIDS, Tuberculosis and Malaria have been turned down in five of the Fund's eight funding rounds since its formation in 2002.

When the country recently received a US$37.9 million grant from the Global Fund, government officials said they hoped this marked the end of a particularly prickly patch. IRIN/PlusNews takes a look at the relationship through the years.

July 2004

Zimbabwe's application to the Fund for a grant of US$218 is rejected due to "several technical shortcomings", but the government appeals to the international donor to reconsider.

In the meantime the first batch of money has been received from the US President's Emergency Plan for AIDS Relief (PEPFAR), launched in 2003.

PEPFAR has remained a steady funder of the AIDS fight since 2004, but funding levels to Zimbabwe pale in comparison to nearby countries with similar HIV prevalence rates, like Zambia and Namibia. In 2008, Zimbabwe received about $26.4 million from PEPFAR - 10 times less than the allocation to Zambia, and about a quarter of what Namibia received.

October 2004

The Global Fund stands by its earlier decision to deny funding. The move draws sharp criticism from Zimbabwe's then Minister of Health and Child Welfare, David Parirenyatwa, who calls it "politically motivated", a sentiment shared by some AIDS activists in the country. The Fund denies the allegations.

2006

In Round 5 of funding, Zimbabwe secures about $33 million to scale up treatment, and voluntary counselling and testing (VCT), in about half the country's 63 districts.

2007

The Fund provides $4.8 million to strengthen prevention and care; Zimbabwe had requested about $14.1 million.

2008

By this time the aid agency has disbursed just over $39 million in Zimbabwe, helping to enrol 13,000 people in AIDS treatment programmes and supply 330,000 insecticide-treated bed nets to combat malaria.

The Reserve Bank of Zimbabwe (RBZ) admits to diverting over $7 million from the Global Fund's Round 5 grant, earmarked for scaling up the national antiretroviral (ARV) programme.

The Global Fund warns that no future grants will be approved until the money is returned. The RBZ eventually returns the money and in Round 8 the Fund approves three grants for Zimbabwe, including $79 million for HIV/AIDS.

2009

The Global Fund decides to bypass Zimbabwe's National AIDS Council (NAC) as the principal recipient of existing and future grants. Money will instead be channelled through the United Nations Development Programme (UNDP).

August 2009

Zimbabwe receives $37.9 million from the Global Fund. At a ceremony in the capital, Harare, Prime Minister Morgan Tsvangirai and Dr Fareed Abdullah, the Fund's regional head for Africa, acknowledge the tumultuous relationship between donor and country. Abdullah describes the disbursement as a turning point "between a troubled past and what we hope to be a somewhat easier future."


090812
IR090814


Copyright © 2009 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980 – 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .